Advertisement
Advertisement

FMS

FMS logo

Fresenius Medical Care AG

24.27
USD
Sponsored
+0.17
+0.71%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

24.29

+0.02
+0.06%

Fresenius Medical Care AG Profile

About

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..

Info & Links

CEO

Helen Giza

Headquarters

ELSE-KROENER STRASSE 1
BAD HOMBURG, 2M 61352, GERMANY

Industry

Medical Instruments

Sector

Medical

Website

www.freseniusmedicalcare.com

Auditor

PricewaterhouseCoopers GmbH

Share holders

2,007

Employees

1,488

Fresenius Medical Care AG Statistics

Valuation Measures

Market Capitalization2

12.92B

Enterprise Value

20.49B

Enterprise Value/EBITDA(ttm)

5.26

Price to Earnings Ratio(ttm)

9.12

Price to Sales(ttm)

0.58

Price to Book(mrq)

0.83

Price to Cash(ytd)

4.36

Profitability

Gross Margin(ttm)

26.30%

Operating Margin(ttm)

6.63%

Profit Margin(ttm)

4.73%

Return on Equity(ttm)

9.28%

Return on Invested Capital(ttm)

5.98%

Return on Assets(ttm)

4.16%

Income Statement

Revenue(ttm)

22.67B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

5.97B

EBITDA(ttm)3

3.90B

Net Income Available to Common(ttm)

1.08B

Diluted EPS(ttm)

1.93

Share Statistics

Beta (5Y Monthly)

0.77

52-Week Change

1.89%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

2.50%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

8.37%

Balance Sheet

Total Cash(mrq)

1.69B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

8.80B

Total Debt/Equity(mrq)

55.91%

Current Ratio(mrq)

1.07%

Quick Ratio(mrq)

0.86%

Book Value Per Share(mrq)

29.56

Cash Flow

Operating Cash Flow Per Share(ytd)

2.35

Free Cash Flow(ytd)

773.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement